Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 May 6;20(7):1391–1397. doi: 10.1158/1055-9965.EPI-11-0022

Table 1.

Distribution of selected characteristics of breast cancer patients according to oral contraceptive (OC) use status in the Women's Contraceptive and Reproductive Experiences (CARE) Study and the California Teachers Study (CTS).

Women's CARE Study
CTS (age 35–64)
CTS (all)
(N=4565) (N=2222) (N=3929)



OC use OC use OC use



Never (N=1041) Ever (N=3524) Never (N=395) Ever (N=1827) Never (N=1490) Ever (N=2439)



Age at diagnosis (y)
 <35 0.1 0.3
 35–39 7.6 17.3 1.3 2.6 0.3 1.9
 40–44 8.4 19.0 5.8 3.8 1.5 2.8
 45–49 8.7 19.6 10.9 11.2 2.9 8.4
 50–54 15.0 19.5 19.5 22.8 5.2 17.1
 55–59 22.9 15.0 24.3 32.3 6.4 24.2
 60–64 37.6 9.6 38.2 27.4 10.1 20.5
 >64 73.4 24.8
Race
 White 62.8 65.0 83.0 88.9 88.4 89.4
 Black (CARE)/Other (CTS) 37.2 35.0 17.0 11.1 11.6 10.6
Family history of breast cancer (first degree)
 No 77.6 79.4 76.4 80.0 79.7 79.3
 Yes 17.4 16.9 19.8 17.2 17.0 17.9
 Adopt/Unknown 5.0 3.7 3.8 2.8 3.3 2.8
Body Mass Index (kg/m2) *
 <20 8.3 11.4 9.4 9.7 7.1 8.7
 20–24.9 37.6 47.7 44.6 50.5 43.4 49.6
 25–29.9 27.8 25.7 30.4 23.8 30.7 24.8
 ≥30 25.8 14.7 12.9 13.7 13.4 14.0
 Unknown 0.6 0.6 2.8 2.4 5.5 2.9
Menopausal status
 Premenopausal 24.3 52.8 38.0 41.3 10.3 31.2
 Postmenopausal 68.1 34.3 53.9 41.2 87.5 55.3
 Unknown 7.6 12.9 8.1 17.6 2.2 13.5
Stage
 Localized 62.7 59.6 67.1 64.4 70.8 66.7
 Non-localized 37.3 40.4 32.9 35.6 29.2 33.3
Estrogen status
 Positive 64.7 57.0 73.7 72.5 73.6 72.8
 Negative 21.3 30.8 12.9 14.7 11.4 14.2
 Unknown 14.0 12.2 13.4 12.8 15.0 13.0
Study site
 Atlanta 19.3 19.3
 Seattle 18.4 24.8
 Detroit 15.3 14.7
 Philadelphia 20.9 13.8
 Los Angeles 26.1 27.5
Education
 Not a High School Graduate 16.3 6.5
 High School Graduate 34.9 27.5
 Some College or Technical School 26.4 34.2
 College Graduate 22.3 31.8
Socioeconomic status
 Lowest quartile 3.8 3.2 4.5 3.3
 2nd quartile 13.9 14.7 16.3 14.4
 3rd quartile 28.6 30.8 30.5 30.5
 Highest quartile 52.9 50.4 47.6 50.7
 Unknown 0.8 1.0 1.1 1.1
*

Body mass index: at 5 years before breast cancer diagnosis for the CARE Study and at cohort entry for the CTS.